Download MendeleyBiochemical and Structural Characterization of a Peptidic Inhibitor of the YAP:TEAD Interaction That Binds to the alpha-Helix Pocket on TEAD.
Mesrouze, Y., Gubler, H., Villard, F., Boesch, R., Ottl, J., Kallen, J., Reid, P.C., Scheufler, C., Marzinzik, A.L., Chene, P.(2023) ACS Chem Biol 18: 643-651
- PubMed: 36825662
- DOI: https://doi.org/10.1021/acschembio.2c00936
- Primary Citation of Related Structures:
8C17 - PubMed Abstract:
The TEAD transcription factors are the most distal elements of the Hippo pathway, and their transcriptional activity is regulated by several proteins, including YAP. In some cancers, the Hippo pathway is deregulated and inhibitors of the YAP:TEAD interaction are foreseen as new anticancer drugs. The binding of YAP to TEAD is driven by the interaction of an α-helix and an Ω-loop present in its TEAD-binding domain with two distinct pockets at the TEAD surface. Using the mRNA-based display technique to screen a library of in vitro -translated cyclic peptides, we identified a peptide that binds with a nanomolar affinity to TEAD. The X-ray structure of this peptide in complex with TEAD reveals that it interacts with the α-helix pocket. Under our experimental conditions, this peptide can form a ternary complex with TEAD and YAP. Furthermore, combining it with a peptide binding to the Ω-loop pocket gives an additive inhibitory effect on the YAP:TEAD interaction. Overall, our results show that it is possible to identify nanomolar inhibitors of the YAP:TEAD interaction that bind to the α-helix pocket, suggesting that developing such compounds might be a strategy to treat cancers where the Hippo pathway is deregulated.
Organizational Affiliation:
Disease Area Oncology, Novartis Institutes for Biomedical Research, CH-4056 Basel, Switzerland.
